Details

Autor(en) / Beteiligte

• Liu, Jin-Yuan
• Deng, Jing-Yu
• Zhang, Nan-Nan
• Liu, Hui-Fang
• Sun, Wei-Lin
• He, Wen-Ting
• Wang, Yan
• Zhang, Li
• Liang, Han

Titel

Clinical significance of skip lymph-node metastasis in pN1 gastric-cancer patients after curative surgery

Ist Teil von

• Gastroenterology report, 2019-06, Vol.7 (3), p.193-198

Ort / Verlag

England: Oxford University Press

Erscheinungsjahr

2019

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• In addition to the stepwise manner of lymph-node metastasis from the primary tumour, the skip lymph-node metastasis (SLNM) was identified as a low-incidence metastasis of gastric cancer (GC). So far, both the mechanism and outcome of SLNM have not been elucidated completely. The purpose of this study was to analyse the clinical significance and the potential mechanism of SLNM in GC patients who had lymph-node metastasis. Clinicopathological data and follow-up information of 505 GC patients who had lymph-node metastasis were analysed to demonstrate the significance of SLNM in evaluating the prognostic outcome. According to the pathological results, all GC patients who had lymph-node metastasis were categorized into three groups: patients with the perigastric lymph-node metastasis, patients with the perigastric and extragastric lymph-node metastasis and patients with SLNM.Results: Among the 505 GC patients who had lymph-node metastasis, 24 (4.8%) had pathologically identified SLNM. The location of lymph-node metastasis was not significantly associated with 5-year survival rate and overall survival (OS) (  = 0.194). The stratified survival analysis results showed that the status of SLNM was significantly associated with the OS in patients with pN1 GC (  = 0.001). The median OS was significantly shorter in 19 pN1 GC patients with SLNM than in 100 patients with perigastric lymph-node metastasis (  < 0.001). The case-control matched logistic regression analysis results showed that tumour size (  = 0.002) was the only clinicopathological factor that may predict SLNM in pN1 GC patients undergoing curative surgery. Among the 19 pN1 GC patients with SLNM, 17 (89.5%) had metastatic lymph nodes along the common hepatic artery, around the celiac artery or in the hepatoduodenal ligament. SLNM may be considered a potentially practicable indicator for prognosis among various subgroups of pN1 GC patients.